The leadership team at Sanzyme is well aware of the vast market potential of fertility hormones and gonadotropins worldwide. However, it is impractical to get the drugs across markets under our brand name by merely collaborating with pharma marketers. The business development team of Sanzyme, therefore, has built a revolutionary concept, perhaps the first in the international market, for sex gonadotropins foraying into contract manufacturing of the drugs for other pharma companies under their brand name. These pharma giants already have well-established brand name and marketing networks. Sanzyme has successfully implemented this in the domestic market in India and realized the true potential of the drugs if supplied through contract manufacturing in addition to the indigenous brands created by Sanzyme. The same concept has now been expanded to hit international markets. Sanzyme has invited leading pharma brands worldwide to collaborate for the same.
Sanzyme aims to become a global name in the infertility drugs market by establishing a network.